V. Caussanel

Selection criteria for c-Met-targeted therapies: emerging evidence for biomarkers.

L. Goetsch, V. Caussanel, Liliane Goetsch, 2010, Biomarkers in medicine.

Biological significance and targeting of c-Met tyrosine kinase receptor in cancer.

L. Goetsch, V. Caussanel, N. Corvaia, 2013, Frontiers in bioscience.

Cellular distribution of transforming growth factor betas 1, 2, and 3 and their types I and II receptors during postnatal development and spermatogenesis in the boar testis.

M. Benahmed, E. Tabone, V. Caussanel, 1997, Biology of reproduction.

[Immunotoxins and immunocytokines].

A. Beck, V. Caussanel, Alicia Contet, 2019, Medecine sciences : M/S.

Tumor necrosis factor alpha receptor p55 is under hormonal (follicle-stimulating hormone) control in testicular Sertoli cells.

M. Benahmed, C. Mauduit, V. Caussanel, 1996, Biochemical and biophysical research communications.

Cellular distribution of EGF, TGFα and their receptor during postnatal development and spermatogenesis of the boar testis

M. Benahmed, C. Mauduit, E. Tabone, 1996, Molecular and Cellular Endocrinology.

Insulin-like growth factor receptor type I as a target for cancer therapy.

Alain Beck, A. Beck, L. Goetsch, 2013, Frontiers in bioscience.

Development of novel protein scaffolds as alternatives to whole antibodies for imaging and therapy: status on discovery research and clinical validation.

T Wurch, P Lowe, V Caussanel, 2008, Current pharmaceutical biotechnology.